Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. (February 2020) - Loglio, A.; Ferenci, P.; Schlund, F.; Tham, C.Y.L.; van Bömmel, F.; Renteria, SC. Uceda; Borghi, M.; Holzmann, H.; Perbellini, R.; Trombetta, E.; Giovanelli, S.; Porretti, L.; et al.